Works matching IS 03407004 AND DT 2019 AND VI 68 AND IP 3

Results: 16

Chronic retroviral infection of mice promotes tumor development, but CD137 agonist therapy restores effective tumor immune surveillance.
Published in:
Cancer Immunology, Immunotherapy, 2019, v. 68, n. 3, p. 479, doi. 10.1007/s00262-019-02300-4
By:
- Malyshkina, Anna;
- Littwitz-Salomon, Elisabeth;
- Sutter, Kathrin;
- Ross, Jean Alexander;
- Paschen, Annette;
- Windmann, Sonja;
- Schimmer, Simone;
- Dittmer, Ulf
Publication type:
Article
Immunotherapy with checkpoint inhibitors in non-small cell lung cancer: insights from long-term survivors.
Published in:
Cancer Immunology, Immunotherapy, 2019, v. 68, n. 3, p. 341, doi. 10.1007/s00262-019-02310-2
By:
- Nadal, Ernest;
- Massuti, Bartomeu;
- Dómine, Manuel;
- García-Campelo, Rosario;
- Cobo, Manuel;
- Felip, Enriqueta
Publication type:
Article
Correction to: CD73 expression in normal and pathological human hepatobiliopancreatic tissues.
Published in:
Cancer Immunology, Immunotherapy, 2019, v. 68, n. 3, p. 529, doi. 10.1007/s00262-019-02309-9
By:
- Sciarra, Amedeo;
- Monteiro, Inês;
- Ménétrier-Caux, Christine;
- Caux, Christophe;
- Gilbert, Benoit;
- Halkic, Nermin;
- La Rosa, Stefano;
- Romero, Pedro;
- Sempoux, Christine;
- de Leval, Laurence
Publication type:
Article
STAT3 inhibition specifically in human monocytes and macrophages by CD163-targeted corosolic acid-containing liposomes.
Published in:
Cancer Immunology, Immunotherapy, 2019, v. 68, n. 3, p. 489, doi. 10.1007/s00262-019-02301-3
By:
- Andersen, Morten Nørgaard;
- Etzerodt, Anders;
- Graversen, Jonas H.;
- Holthof, Lisa C.;
- Moestrup, Søren K.;
- Hokland, Marianne;
- Møller, Holger J.
Publication type:
Article
The route of administration dictates the immunogenicity of peptide-based cancer vaccines in mice.
Published in:
Cancer Immunology, Immunotherapy, 2019, v. 68, n. 3, p. 455, doi. 10.1007/s00262-018-02294-5
By:
- Sultan, Hussein;
- Kumai, Takumi;
- Nagato, Toshihiro;
- Wu, Juan;
- Salazar, Andres M.;
- Celis, Esteban
Publication type:
Article
Distinct immunological properties of the two histological subtypes of adenocarcinoma of the ampulla of Vater.
Published in:
Cancer Immunology, Immunotherapy, 2019, v. 68, n. 3, p. 443, doi. 10.1007/s00262-018-02293-6
By:
- Kim, Min Hwan;
- Jang, Mi;
- Kim, Hoguen;
- Lee, Woo Jung;
- Kang, Chang Moo;
- Choi, Hye Jin
Publication type:
Article
CD73 expression in normal and pathological human hepatobiliopancreatic tissues.
Published in:
Cancer Immunology, Immunotherapy, 2019, v. 68, n. 3, p. 467, doi. 10.1007/s00262-018-2290-1
By:
- Sciarra, Amedeo;
- Monteiro, Inês;
- Ménétrier-Caux, Christine;
- Caux, Christophe;
- Gilbert, Benoit;
- Halkic, Nermin;
- La Rosa, Stefano;
- Romero, Pedro;
- Sempoux, Christine;
- de Leval, Laurence
Publication type:
Article
Immune cell infiltration as a biomarker for the diagnosis and prognosis of stage I-III colon cancer.
Published in:
Cancer Immunology, Immunotherapy, 2019, v. 68, n. 3, p. 433, doi. 10.1007/s00262-018-2289-7
By:
- Zhou, Rui;
- Zhang, Jingwen;
- Zeng, Dongqiang;
- Sun, Huiying;
- Rong, Xiaoxiang;
- Shi, Min;
- Bin, Jianping;
- Liao, Yulin;
- Liao, Wangjun
Publication type:
Article
The effect of everolimus and low-dose cyclophosphamide on immune cell subsets in patients with metastatic renal cell carcinoma: results from a phase I clinical trial.
Published in:
Cancer Immunology, Immunotherapy, 2019, v. 68, n. 3, p. 503, doi. 10.1007/s00262-018-2288-8
By:
- Huijts, Charlotte M.;
- Lougheed, Sinéad M.;
- Bodalal, Zuhir;
- van Herpen, Carla M.;
- Hamberg, Paul;
- Tascilar, Metin;
- Haanen, John B.;
- Verheul, Henk M.;
- de Gruijl, Tanja D.;
- van der Vliet, Hans J.;
- for the Dutch WIN-O Consortium
Publication type:
Article
Randomized-controlled phase II trial of salvage chemotherapy after immunization with a TP53-transfected dendritic cell-based vaccine (Ad.p53-DC) in patients with recurrent small cell lung cancer.
Published in:
Cancer Immunology, Immunotherapy, 2019, v. 68, n. 3, p. 517, doi. 10.1007/s00262-018-2287-9
By:
- Chiappori, Alberto A.;
- Williams, Charles C.;
- Gray, Jhanelle E.;
- Tanvetyanon, Tawee;
- Haura, Eric B.;
- Creelan, Ben C.;
- Thapa, Ram;
- Chen, Dung-Tsa;
- Simon, George R.;
- Bepler, Gerold;
- Gabrilovich, Dmitry I.;
- Antonia, Scott J.
Publication type:
Article
Identification and characterization of an alternative cancer-derived PD-L1 splice variant.
Published in:
Cancer Immunology, Immunotherapy, 2019, v. 68, n. 3, p. 407, doi. 10.1007/s00262-018-2284-z
By:
- Hassounah, Nadia B.;
- Malladi, Venkat S.;
- Huang, Yi;
- Freeman, Samuel S.;
- Beauchamp, Ellen M.;
- Koyama, Shohei;
- Souders, Nicholas;
- Martin, Sunil;
- Dranoff, Glenn;
- Wong, Kwok-Kin;
- Pedamallu, Chandra S.;
- Hammerman, Peter S.;
- Akbay, Esra A.
Publication type:
Article
Enhanced anti-tumor efficacy of checkpoint inhibitors in combination with the histone deacetylase inhibitor Belinostat in a murine hepatocellular carcinoma model.
Published in:
Cancer Immunology, Immunotherapy, 2019, v. 68, n. 3, p. 379, doi. 10.1007/s00262-018-2283-0
By:
- Llopiz, Diana;
- Ruiz, Marta;
- Villanueva, Lorea;
- Iglesias, Tamara;
- Silva, Leyre;
- Egea, Josune;
- Lasarte, Juan J.;
- Pivette, Perrine;
- Trochon-Joseph, Véronique;
- Vasseur, Bérangère;
- Dixon, Graham;
- Sangro, Bruno;
- Sarobe, Pablo
Publication type:
Article
A secreted PD-L1 splice variant that covalently dimerizes and mediates immunosuppression.
Published in:
Cancer Immunology, Immunotherapy, 2019, v. 68, n. 3, p. 421, doi. 10.1007/s00262-018-2282-1
By:
- Mahoney, Kathleen M.;
- Shukla, Sachet A.;
- Patsoukis, Nikolaos;
- Chaudhri, Apoorvi;
- Browne, Edward P.;
- Arazi, Arnon;
- Eisenhaure, Thomas M.;
- Pendergraft, William F.;
- Hua, Ping;
- Pham, Hung C.;
- Bu, Xia;
- Zhu, Baogong;
- Hacohen, Nir;
- Fritsch, Edward F.;
- Boussiotis, Vassiliki A.;
- Wu, Catherine J.;
- Freeman, Gordon J.
Publication type:
Article
CRISPR/Cas9-mediated PD-1 disruption enhances human mesothelin-targeted CAR T cell effector functions.
Published in:
Cancer Immunology, Immunotherapy, 2019, v. 68, n. 3, p. 365, doi. 10.1007/s00262-018-2281-2
By:
- Hu, Wanghong;
- Zi, Zhenguo;
- Jin, Yanling;
- Li, Gaoxin;
- Shao, Kang;
- Cai, Qiliang;
- Ma, Xiaojing;
- Wei, Fang
Publication type:
Article
Ex vivo conditioning with IL-12 protects tumor-infiltrating CD8<sup>+</sup> T cells from negative regulation by local IFN-γ.
Published in:
Cancer Immunology, Immunotherapy, 2019, v. 68, n. 3, p. 395, doi. 10.1007/s00262-018-2280-3
By:
- Lin, Lin;
- Rayman, Patricia;
- Pavicic, Paul G.;
- Tannenbaum, Charles;
- Hamilton, Thomas;
- Montero, Alberto;
- Ko, Jennifer;
- Gastman, Brian;
- Finke, James;
- Ernstoff, Marc;
- Diaz-Montero, C. Marcela
Publication type:
Article
The correlation and prognostic value of serum levels of soluble programmed death protein 1 (sPD-1) and soluble programmed death-ligand 1 (sPD-L1) in patients with hepatocellular carcinoma.
Published in:
Cancer Immunology, Immunotherapy, 2019, v. 68, n. 3, p. 353, doi. 10.1007/s00262-018-2271-4
By:
- Chang, Boyang;
- Huang, Tao;
- Wei, Huajun;
- Shen, Lujun;
- Zhu, Duo;
- He, Wenjun;
- Chen, Qifeng;
- Zhang, Huihua;
- Li, Yunjian;
- Huang, Ruopan;
- Li, Wang;
- Wu, Peihong
Publication type:
Article